Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
unknown

Coronary Interventions Ulm - Coronary Chronic Total Occlusions

NCT04650139
completednot_applicable

Novel Angioplasty Using Coronary Accessor

NCT00815997
completed

MR, Myocardial Infarct and Heart Failure

NCT00465868
completedphase_4

WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)

NCT00769938

Clinical Trials (4)

Showing 4 of 4 trials
NCT04650139

Coronary Interventions Ulm - Coronary Chronic Total Occlusions

Unknown
NCT00815997Not Applicable

Novel Angioplasty Using Coronary Accessor

Completed
NCT00465868

MR, Myocardial Infarct and Heart Failure

Completed
NCT00769938Phase 4

WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4